Integrating Next-Generation Sequencing Disease Evaluation and PCR Based CAR-T cell Tracking to Guide Decision Making in a Real-World Cohort of Pediatric B-cell ALL Patients.

Key Points

• Integration of next-generation sequencing and PCR significantly enhances decision-making in B-cell ALL treatment.
• The approach improves tracking of CAR-T cells in real-world pediatric populations, ensuring targeted therapies are effective.
• Observational study leverages sequencing data alongside CAR-T therapy to optimize treatment paths for children with ALL.
• Findings support more personalized care strategies in pediatric oncology, addressing critical gaps in traditional monitoring.